A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer

JOURNAL ARTICLE published 1 January 2016 in Clinical Cancer Research

Authors: Martin Schlumberger | Barbara Jarzab | Maria E. Cabanillas | Bruce Robinson | Furio Pacini | Douglas W. Ball | Judith McCaffrey | Kate Newbold | Roger Allison | Renato G. Martins | Lisa F. Licitra | Manisha H. Shah | Donald Bodenner | Rossella Elisei | Lynn Burmeister | Yasuhiro Funahashi | Min Ren | James P. O'Brien | Steven I. Sherman